Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boulder/denver blog main
boulder/denver top stories
crispr
6
×
detroit blog main
detroit top stories
indiana blog main
6
×
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
6
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer
ipo
novartis
biogen
deals
fda
startups
abbvie
cancer immunotherapy
clinical trials
eli lilly
gene therapy
What
bio
roundup
life
new
science
companies
ipo
millions
moves
remains
talk
therapeutics
years
acquisitions
allogene
announced
approval
bails
becker
billions
biogen’s
biopharmaceutical
black
brand
bridgebio
cancer
capital
car
ceo
collabs
continue
convo
covid
crispr
daniel
deal
debut
develop
diamond
diamond’s
Language
unset
Current search:
crispr
×
biotech
×
" san diego blog main "
×
" indiana blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More